Cargando…

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice

Detalles Bibliográficos
Autores principales:	Zhang, Hang, Yang, Fan, Xiao, Yi, Jiang, Yi-Zhou, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978894/ https://www.ncbi.nlm.nih.gov/pubmed/36861444 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0767

Ejemplares similares

Conceptualizations and Limitations of STEM Literacy across Learning Theories
por: Tenney, Kristin, et al.
Publicado: (2023)

Immunotherapy for early triple negative breast cancer: research agenda for the next decade
por: Tarantino, Paolo, et al.
Publicado: (2022)

Simvastatin induced ferroptosis for triple-negative breast cancer therapy
por: Yao, Xianxian, et al.
Publicado: (2021)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Identifying Reservoirs of Infection: A Conceptual and Practical Challenge
Publicado: (2002)

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
por: Nguyen, Khoa, et al.
Publicado: (2022)

Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
por: Zhao, Hongting, et al.
Publicado: (2023)

Translating the role of PARP inhibitors in triple-negative breast cancer
por: Beniey, Michèle, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
por: Zhou, Yi-Fan, et al.
Publicado: (2021)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Triple negative breast cancer: looking for the missing link between biology and treatments
por: Palma, Giuseppe, et al.
Publicado: (2015)

Practical assessment of risk of VILI from ventilating power: a conceptual model
por: Marini, John J., et al.
Publicado: (2023)

A novel eight-gene Immune Cell-Associated Predictive Gene model to predict recurrence in triple-negative breast cancer
por: Sui, Xin-Yi, et al.
Publicado: (2023)

Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
por: Chen, Hsin-Chih, et al.
Publicado: (2022)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Mitochondrial regulation of ferroptosis
por: Gan, Boyi
Publicado: (2021)

Sacituzumab govitecan in metastatic triple negative breast cancer (TNBC): Four design features in the ASCENT trial potentially favored the experimental arm
por: Olivier, Timothee, et al.
Publicado: (2021)

Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
por: Zhang, Jiali, et al.
Publicado: (2023)

Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women
por: Ling, Hong, et al.
Publicado: (2016)

A conceptual framework for consciousness
por: Graziano, Michael S. A.
Publicado: (2022)

Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
por: Yu, Mengyu, et al.
Publicado: (2019)

Opportunities for Ferroptosis in Cancer Therapy
por: Fujihara, Kenji M., et al.
Publicado: (2021)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
por: Ding, Jia-Han, et al.
Publicado: (2022)

Conceptualizations of Health Literacy: Past Developments, Current Trends, and Possible Ways Forward Toward Social Practice
por: Pinheiro, Paulo
Publicado: (2021)

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis
por: Gao, Chong, et al.
Publicado: (2019)

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
por: Jiang, Lin, et al.
Publicado: (2022)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

Lycium barbarum polysaccharides and ferroptosis: jumping into the era of novel regulated cell death
por: Lo, Amy Cheuk Yin, et al.
Publicado: (2021)

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
por: Song, Xiang, et al.
Publicado: (2020)

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
por: Wu, Song, et al.
Publicado: (2022)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
por: Fang, Kun, et al.
Publicado: (2022)

Clinical research informatics: a conceptual perspective
por: Kahn, Michael G, et al.
Publicado: (2012)

Organizational Food Environments: Advancing Their Conceptual Model
por: de Castro, Inês Rugani Ribeiro, et al.
Publicado: (2022)

Conceptualizing controversies in the EU circular bioeconomy transition
por: Starke, Jan R., et al.
Publicado: (2022)

Ferroptosis and glaucoma: implications in retinal ganglion cell damage and optic nerve survival
por: Yang, Ming, et al.
Publicado: (2022)

PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis
por: Wang, Zhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t74vo3aie0cfdh0nrdmtit4e88